You are here: Welcome » Medical Publications

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
medical_publications [2021/12/06 20:23]
brian [Covid-19 Publications & Regulatory Announcements: Organised Link Dump]
medical_publications [2021/12/08 18:24] (current)
brian [Covid-19 Publications & Regulatory Announcements: Organised Link Dump]
Line 67: Line 67:
 [[https://www.medrxiv.org/content/10.1101/2020.07.09.20143339v2|Association between SSRI Antidepressant Use and Reduced Risk of Intubation or Death in Hospitalized Patients with Coronavirus Disease 2019: a Multicenter Retrospective Observational Study]] \\ [[https://www.medrxiv.org/content/10.1101/2020.07.09.20143339v2|Association between SSRI Antidepressant Use and Reduced Risk of Intubation or Death in Hospitalized Patients with Coronavirus Disease 2019: a Multicenter Retrospective Observational Study]] \\
  
 +** Risk of Hospitalization, severe disease, and mortality due to COVID-19 ** \\
 +
 +[[https://www.medrxiv.org/content/10.1101/2021.11.30.21267048v1|Risk of Hospitalization, severe disease, and mortality due to COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany]] \\
  
 ** Vaccine Development & Approval ** ** Vaccine Development & Approval **
Line 74: Line 77:
 [[https://www.fda.gov/media/144325/download | The Pfizer science, as presented to the FDA in December 2020]]. [[https://www.fda.gov/media/144325/download | The Pfizer science, as presented to the FDA in December 2020]].
  
-** Risk of Hospitalization, severe disease, and mortality due to COVID-19 ** 
-[[https://www.medrxiv.org/content/10.1101/2021.11.30.21267048v1|Risk of Hospitalization, severe disease, and mortality due to COVID-19 and PIMS-TS in children with SARS-CoV-2 infection in Germany]] \\ 
  
 ** Vaccinating Children ** ** Vaccinating Children **
Line 141: Line 142:
 [[https://www.nature.com/articles/s41564-021-00954-4|SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution]] \\ [[https://www.nature.com/articles/s41564-021-00954-4|SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution]] \\
  
 +[[https://www.sciencedirect.com/science/article/pii/S0048969721071485?via%3Dihub|CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target]] \\
  
  
Back to top